Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Assets Average (2021 - 2026)

Rani Therapeutics Holdings' Assets Average history spans 6 years, with the latest figure at $55.2 million for Q1 2026.

  • On a quarterly basis, Assets Average rose 81.87% to $55.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $55.2 million, a 81.87% increase, with the full-year FY2025 number at $47.6 million, up 0.75% from a year prior.
  • Assets Average came in at $55.2 million for Q1 2026, up from $34.4 million in the prior quarter.
  • The five-year high for Assets Average was $119.8 million in Q1 2022, with the low at $13.5 million in Q3 2025.
  • Historically, Assets Average has averaged $65.8 million across 5 years, with a median of $55.7 million in 2024.
  • Biggest five-year swings in Assets Average: crashed 69.02% in 2025 and later skyrocketed 81.87% in 2026.
  • Year by year, Assets Average stood at $108.1 million in 2022, then plummeted by 40.64% to $64.2 million in 2023, then crashed by 37.54% to $40.1 million in 2024, then decreased by 14.24% to $34.4 million in 2025, then surged by 60.7% to $55.2 million in 2026.
  • Business Quant data shows Assets Average for RANI at $55.2 million in Q1 2026, $34.4 million in Q4 2025, and $13.5 million in Q3 2025.